Description
This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present.
The report offers a quantitative assessment of specific markets, worldwide, in US dollars for 2007 to 2012.
With the reported growing epidemic of diabetes, worldwide, it is widely held that glucose self testing and diabetes management are among the fastest growing areas in health care.
compiled from various Kalorama reports including Kalorama’s Glucose Testing, The Worldwide Market for Diagnostic Tests, 6th Edition, and Diabetes and Diabetic Complications, 2nd edition, A comprehensive look at the world glucose monitoring market, this survey includes:
- Markets and Forecasts for POC Self-Testing By Region(U.S., Asia, Europe, Rest of World)
- World Market and Forecasted Market for Professional Glucose Testing
- Diabetes Epidemology for Major Countries
- Review of Innovative Glucose Monitoring Products
- Market Share
- Company Profiles
- Predictions on the Future of Glucose Monitoring Products.
As with all Kalorama Information reports, this study is the result of exhaustive research and interviews with experts in the diagnostic industry. Shara Rosen is the author of Kalorama’s best-selling Worldwide Market for In Vitro Diagnostic Testing, 6th Edition, a resource used by most major diagnostic companies in decision making and market estimates.
Table of Contents
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
- Scope and Objectives
- Methodology of Investigation
- Limitations of the research
- A Word About Diabetes
- Markets
- Professional and POC Glucose Testing
- Glucose Self-Testing
CHAPTER TWO: INTRODUCTION
- Background
- The Pathology of Diabetes and Its Complications
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Epidemiology
- Diabetes in UK, U.S., Spain, Germany, Italy, France, Japan and U.S.
CHAPTER THREE: GLUCOSE MONITORING MARKETS
- Total Market
- Professional Glucose Testing
- Glucose Self-Testing
- Non-Invasive Products
- Innovative Glucose Monitoring Products
CHAPTER FOUR: COMPANY PROFILES
- MAJOR COMPETITORS
- Bayer Diabetes Care
- Roche Diagnostics
- Abbott Diagnostics
- Lifescan Inc.
- COMPANIES TO WATCH
- 77 Elektronika Kft.
- AgaMatrix, Inc.
- Agilent Technologies Inc.
- Alere Medical Inc.
- ARKRAY
- BIOSAFE Medical Technologies, Inc.
- Biosign Technologies Inc.
- BodyTel Scientific Inc.
- DexCom, Inc.
- Diabetech, LP
- GlucoLight Corporation
- GlucoStats System
- GlucoTec, Inc.
- HealthPia America
- Heidelberger-Medical-Marketing GmbH (HMM GmbH)
- HemoCue AB
- Integrity Applications Ltd.
- Luminous Medical, Inc.
- Medtronic Inc.
- A. Menarini Diagnostics
- Menssana Research, Inc.
- OrSense Ltd.
- Oxonica Healthcare
- Philips Medical Systems
- Quadraspec
- Quotient Diagnostics
- RainDance Technologies, Inc. (RDT)
- Roche Diagnostics
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1 World Market for Glucose Testing
- Table 1-1: Glucose Monitoring Self-Testing Sales 2007-2012
- Figure 1-2: Glucose Monitoring Self-Testing Sales 2007-2012
CHAPTER TWO: INTRODUCTION
- Table 2-1: Characteristics of Type I and Type II Diabetes Mellitus
- Table 2-2: Common Symptoms and Conditions of Diabetes Mellitus
- Table 2-4: Populations of Each of the Seven Major World Healthcare Markets by Age Group (0-14, 15-64, 65+ Years) 2006
- Table 2-5: Prevalence Rates and Cases for Diabetes Mellitus by Type (Type I vs Type II) in Seven Major World Healthcare Markets 2006
- Table 2-6: Prevalence of Diabetes in Seven Major World Healthcare Markets by Type (I vs II) 2004-2016
- Figure 2-1: Trending in the Total Prevalence of Diabetes Cases and the General Population in the Seven Major World Healthcare Markets 2006 – 2016
- Figure 2-2: Composition of the Diabetes Patient Population in the Seven Major World Healthcare Markets 2006-2016
- Figure 2-3: Geographic Distribution of the Total Diabetes Patient Population: 2006 and 2016
- Figure 2-4: Geographic Distribution of the Type 1 Diabetes Patient Population 2006 and 2016
- Figure 2-5: Geographic Distribution of the Type 2 Diabetes Patient Population 2006 and 2016
- Figure 2-6: Population Trends in Seven Major World Healthcare Markets: 2006-2016
CHAPTER THREE: GLUCOSE MONITORING MARKETS
- Table 3-1: Glucose Monitoring Self-Testing Sales by Region (US, Europe, Asia, ROW)
- Table 3-2: Glucose Monitoring Self-Testing (OTC) Sales by Region (US, Europe, Asia, ROW)
- Table 3-3: Estimated World Glucose Monitoring Sales by Company 2005-2007
- Table 3-4: Selected Blood Glucose Test Devices Innovations, 2006-2007
- Figure 3-5: Technology Market Penetration Forecast for New Device Users 2007 – 2020
